GRIFOLS | GRF - Des Atouts





Des Atouts Changement Date
Alcon AG USD 31.56B 31M 2025-12
Almirall EUR 2.34B 29.21M 2025-12
Amadeus IT EUR 11.47B 108.4M 2025-12
Amarin USD 670.78M 10.96M 2025-12
argenx SE USD 7.18B 973.07M 2025-06
AstraZeneca USD 114.07B 382M 2025-12
Bayer EUR 104.54B 331M 2025-12
Cie Automotive EUR 5.68B 97.53M 2025-12
Demant DKK 39.07B 6.43B 2025-12
Ence Energia y Celulosa EUR 1.64B 55.33M 2025-12
Essilor EUR 63.9B 1.97B 2025-12
Ferrovial EUR 27.42B 857M 2025-12
Fresenius EUR 42.46B 1.14B 2025-09
Fresenius Medical Care EUR 31B 115.33M 2025-12
Galapagos EUR 3.41B 105.39M 2025-12
Genmab DKK 12.87B 5.85B 2025-12
GlaxoSmithKline GBP 61.12B 221M 2025-12
GRIFOLS EUR 19.71B 141.77M 2025-12
Hikma Pharmaceutical USD 5.67B 117M 2025-12
Inditex EUR 35.64B 1.19B 2025-12
Merck EUR 51.53B 600M 2025-12
Novartis USD 110.95B 3.66B 2025-12
Philips EUR 26.94B 605M 2025-12
Roche Holding CHF 100.7B 5.94B 2025-12
Sanofi EUR 126.81B 2.99B 2025-12
Smith & Nephew USD 10.69B 150M 2025-12
UCB EUR 18.16B 971M 2025-12
Viscofan EUR 1.44B 1.06M 2025-12